Literature DB >> 16891611

Noradrenergic signaling in the amygdala contributes to the reconsolidation of fear memory: treatment implications for PTSD.

Jacek Debiec1, Joseph E LeDoux.   

Abstract

Intrusive memories resulting from an emotional trauma are a defining feature of posttraumatic stress disorder (PTSD). Existing studies demonstrate that an increase of noradrenergic activity during a life-threatening event contributes to strengthening or "overconsolidation" of the memory for trauma. The lateral nucleus of the amygdala (LA) is critical for fear learning. Using classical fear conditioning in rats, we have recently demonstrated that noradrenergic blockade in the LA following reactivation of fear memory by retrieval disrupts memory reconsolidation and lastingly impairs fear memory. This suggests that noradrenergic blockade may be useful in attenuating traumatic memories, even well-consolidated old memories, in PTSD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16891611     DOI: 10.1196/annals.1364.056

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  81 in total

Review 1.  Rodent model of infant attachment learning and stress.

Authors:  Stephanie Moriceau; Tania L Roth; Regina M Sullivan
Journal:  Dev Psychobiol       Date:  2010-11       Impact factor: 3.038

2.  Noradrenergic control of cortico-striato-thalamic and mesolimbic cross-structural synchrony.

Authors:  Kafui Dzirasa; H Westley Phillips; Tatyana D Sotnikova; Ali Salahpour; Sunil Kumar; Raul R Gainetdinov; Marc G Caron; Miguel A L Nicolelis
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

3.  Reconsolidation of a cocaine-associated stimulus requires amygdalar protein kinase A.

Authors:  Hayde Sanchez; Jennifer J Quinn; Mary M Torregrossa; Jane R Taylor
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

4.  Noradrenergic modulation of basolateral amygdala neuronal activity: opposing influences of alpha-2 and beta receptor activation.

Authors:  Deanne M Buffalari; Anthony A Grace
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

Review 5.  Protein synthesis inhibition and memory: formation vs amnesia.

Authors:  Paul E Gold
Journal:  Neurobiol Learn Mem       Date:  2007-12-03       Impact factor: 2.877

Review 6.  Reconsolidation and the fate of consolidated memories.

Authors:  Lia R Bevilaqua; Jorge H Medina; Iván Izquierdo; Martín Cammarota
Journal:  Neurotox Res       Date:  2008-12       Impact factor: 3.911

Review 7.  Drug enhancement of memory consolidation: historical perspective and neurobiological implications.

Authors:  James L McGaugh; Benno Roozendaal
Journal:  Psychopharmacology (Berl)       Date:  2008-08-15       Impact factor: 4.530

Review 8.  Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review.

Authors:  William Berger; Mauro V Mendlowicz; Carla Marques-Portella; Gustavo Kinrys; Leonardo F Fontenelle; Charles R Marmar; Ivan Figueira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-12-24       Impact factor: 5.067

9.  From ideas to efficacy: The ORBIT model for developing behavioral treatments for chronic diseases.

Authors:  Susan M Czajkowski; Lynda H Powell; Nancy Adler; Sylvie Naar-King; Kim D Reynolds; Christine M Hunter; Barbara Laraia; Deborah H Olster; Frank M Perna; Janey C Peterson; Elissa Epel; Josephine E Boyington; Mary E Charlson
Journal:  Health Psychol       Date:  2015-02-02       Impact factor: 4.267

10.  Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging.

Authors:  Sakthivel Sekar; J Van Audekerke; G Vanhoutte; A S Lowe; A M Blamire; A Van der Linden; T Steckler; M Shoaib; Marleen Verhoye
Journal:  Psychopharmacology (Berl)       Date:  2011-05-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.